Influence of ABO blood groups on primary hemostasis

Area of Science:

• Hematology
• Clinical diagnostics
• Blood group immunology

Background:

• The in vitro bleeding time test (IVBT) is a sensitive method for detecting von Willebrand disease (vWD).
• Lower von Willebrand factor (vWF) levels are observed in individuals with blood group O compared to non-group O individuals.
• Previous research suggests a correlation between vWF levels and bleeding time, necessitating further investigation into ABO group differences in primary hemostasis.

Purpose of the Study:

• To investigate whether differences in vWF levels among healthy individuals with different ABO blood groups correlate with variations in nonvascular primary hemostasis.
• To assess the utility of the IVBT in detecting ABO blood group-specific differences in primary hemostasis.

Main Methods:

• 162 healthy blood donors without hemostatic disorders or recent drug use were evaluated using IVBT.
• Two automated IVBT systems were employed: Thrombostat 4000 (TST) and Platelet Function Analyzer (PFA-100).
• TST utilized CaCl2 and ADP as aggregants, while PFA used ADP- or epinephrine-coated membranes.

Main Results:

• Significant correlations were found between IVBT closure times and ABO blood groups across all tested methods (TST-ADP, TST-CaCl2, PFA-ADP, PFA-Epi).
• Individuals in blood group O generally exhibited longer closure times compared to non-group O individuals.
• Donors with lower vWF levels (< or =77.5%) demonstrated longer closure times, further supporting the link between vWF and hemostasis.

Conclusions:

• The IVBT can detect statistically significant ABO blood group-specific differences in nonvascular primary hemostasis.
• These observed differences in hemostasis are small and fall within the normal physiological range.
• The clinical or biological relevance of these minor ABO-group-related hemostatic variations requires further investigation and speculation.